Feedback (LON:FDBK) Trading Down 20.1% – Here’s What Happened

Shares of Feedback plc (LON:FDBK) dropped 20.1% on Monday . The stock traded as low as GBX 11 and last traded at GBX 11.50. Approximately 1,791,872 shares were traded during mid-day trading, an increase of 1,137% from the average daily volume of 144,900 shares. The stock had previously closed at GBX 14.40.

Feedback Stock Performance

The firm’s 50-day moving average is GBX 12.71 and its two-hundred day moving average is GBX 10.73. The stock has a market cap of £4.16 million, a P/E ratio of -0.60 and a beta of 0.77.

Feedback (LON:FDBK) last released its earnings results on Tuesday, February 17th. The company reported GBX (3.98) EPS for the quarter. Feedback had a negative return on equity of 135.17% and a negative net margin of 845.25%. As a group, research analysts forecast that Feedback plc will post -8 EPS for the current year.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.